SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-15-239519
Filing Date
2015-06-29
Accepted
2015-06-29 17:17:20
Documents
30

Document Format Files

Seq Description Document Type Size
1 S-1 d945261ds1.htm S-1 1095760
2 EX-10.30 d945261dex1030.htm EX-10.30 269101
3 EX-23.1 d945261dex231.htm EX-23.1 1801
4 GRAPHIC g945261g00i10.jpg GRAPHIC 59761
5 GRAPHIC g945261g02w96.jpg GRAPHIC 39679
6 GRAPHIC g945261g05i97.jpg GRAPHIC 103582
7 GRAPHIC g945261g18z83.jpg GRAPHIC 26420
8 GRAPHIC g945261g21g77.jpg GRAPHIC 57596
9 GRAPHIC g945261g24s27.jpg GRAPHIC 39066
10 GRAPHIC g945261g28i01.jpg GRAPHIC 23145
11 GRAPHIC g945261g33e10.jpg GRAPHIC 111661
12 GRAPHIC g945261g43a90.jpg GRAPHIC 40019
13 GRAPHIC g945261g43p82.jpg GRAPHIC 52697
14 GRAPHIC g945261g47c23.jpg GRAPHIC 33983
15 GRAPHIC g945261g47x13.jpg GRAPHIC 174903
16 GRAPHIC g945261g52w17.jpg GRAPHIC 31373
17 GRAPHIC g945261g63j96.jpg GRAPHIC 37097
18 GRAPHIC g945261g64s41.jpg GRAPHIC 88993
19 GRAPHIC g945261g66u23.jpg GRAPHIC 26821
20 GRAPHIC g945261g69z60.jpg GRAPHIC 39289
21 GRAPHIC g945261g72o20.jpg GRAPHIC 98334
22 GRAPHIC g945261g73f58.jpg GRAPHIC 27013
23 GRAPHIC g945261g75u40.jpg GRAPHIC 113616
24 GRAPHIC g945261g80v50.jpg GRAPHIC 19648
25 GRAPHIC g945261g84e38.jpg GRAPHIC 23557
26 GRAPHIC g945261g84p01.jpg GRAPHIC 10247
27 GRAPHIC g945261g87x17.jpg GRAPHIC 34589
28 GRAPHIC g945261g97k73.jpg GRAPHIC 3114
29 GRAPHIC g945261g97w67.jpg GRAPHIC 151627
30 GRAPHIC g945261g99n22.jpg GRAPHIC 93409
  Complete submission text file 0001193125-15-239519.txt   3522735
Mailing Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005 415-287-2410
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-205347 | Film No.: 15959208
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences